Equites Radar

HNGE · Hinge Health, Inc.

Health Information ServicesUnited StatesAnalyst view: Buy

$76.69

-2.19% last session

End-of-day data · updated 2026-07-25

Mildly bullish3 bullish · 1 bearish technical signals
Consensus: Buy (1.56 from 15 analysts)
To mean target: +18.5%

Market cap

$6B

Enterprise value

$6B

Trailing P/E

Forward P/E

21.9

Dividend yield

Beta

Avg volume

2M

Employees

1K

2D change

-3.10%

5D change

-15.27%

10D change

-13.34%

30D change

-1.10%

60D change

40.26%

MTD change

-12.65%

YTD change

59.98%

Analyst Outlook

Consensus ratingBuy
Recommendation mean (1–5)1.56
Covering analysts15
Mean price target$90.87
Low price target$65.00
Upside to mean target+18.5%

Analyst estimates change daily — follow the shifts on the Estimate Trends page.

Technical Analysis

RSI (14)41.2
50-day MA$70.67
200-day MA$51.17
Price vs 50-day MA+6.1%
Price vs 200-day MA+46.6%
MACD histogram-2.42
Volume vs 3-month avg0.1×
52w low $31.1752w high $90.00

Analyst sentiment over time — HNGE

Rec Mean (blue, left — higher = more bullish) vs. price targets (right).

Investment Bank Ratings as of 2026-07-27

Latest call per bank · past 12 months

Barclays

Overweight

$97.00

+26.5% vs price
▲ raised from $70.00Maintains · 2026-07-13

Morgan Stanley

Overweight

$108

+40.8% vs price
▲ raised from $72.00Maintains · 2026-07-13

Wells Fargo

Overweight

$90.00

+17.4% vs price
▲ raised from $80.00Maintains · 2026-06-24

RBC Capital

Outperform

$75.00

-2.2% vs price
▲ raised from $65.00Maintains · 2026-06-11

Bank of America

Buy

$64.00

-16.5% vs price
▲ raised from $42.00Maintains · 2025-08-06

Recent rating actions

DateFirmActionRatingPrice target
2026-07-27StifelMaintainsBuy$79.00 $90.00
2026-07-27CitizensMaintainsMarket Outperform$80.00 $96.00
2026-07-21Canaccord GenuityMaintainsBuy$76.00 $100
2026-07-13BarclaysMaintainsOverweight$70.00 $97.00
2026-07-13KeybancMaintainsOverweight$90.00 $125
2026-07-13Morgan StanleyMaintainsOverweight$72.00 $108
2026-06-24Wells FargoMaintainsOverweight$80.00 $90.00
2026-06-17BairdMaintainsNeutral$55.00 $65.00

Ratings and price targets are the published opinions of the issuing banks, compiled from Yahoo Finance rating actions — not investment advice.

Signal Summary as of 2026-07-27

  • RSI (14): RSI is 41 — neutral momentum, neither overbought nor oversold.
  • Price vs 50-day MA: Trading 6.1% above the 50-day MA ($70.67).
  • Price vs 200-day MA: Trading 46.6% above the 200-day MA ($51.17).
  • MA cross: The 50-day MA sits above the 200-day MA (golden-cross regime) — the longer-term trend points up.
  • MACD (12,26,9): MACD histogram is negative (-2.42) — short-term momentum is fading.
  • 52-week range: Price sits between the 52-week low ($31.17) and high ($90.00).

HNGE Price Chart

Loading chart for HNGE

Fundamentals

Revenue (TTM)$1.0B
EBITDA-$1.0B
Free cash flow$0M
Operating cash flow$0M
Book value / share$1.44
Net debt / EBITDA0.6
WACC-1.0%
Revenue growth47.00%
Earnings growth-68.00%

About Hinge Health, Inc.

Hinge Health, Inc. focuses on building a health system that scales and automates the delivery of care using technology. It designs its platform to address musculoskeletal system care (MSK), including acute injury, chronic pain, and post-surgical rehabilitation. The company also provides personalized and automated MSK care through AI-powered motion tracking technology and a proprietary electrical nerve stimulation wearable device. It primarily serves self-insured employers. The company was founded in 2012 and is headquartered in San Francisco, California.

More in Health Information Services

Screen HNGE against the full market on the Radar →

Data is sourced from end-of-day snapshots and refreshed daily before the US market open — nothing on this page is real-time. Figures can contain vendor errors. This page is for information only and is not investment advice.